– IRELAND, Dublin – Malin Corporation plc (ISE:MLC / LSE:IRSH), the Irish-based, global life sciences company, today appointed Ian Curley as Chairman, effective immediately, to continue the focus on developing Malin’s extensive portfolio of assets and achieving the greatest level of shareholder value in the medium term. Malin also appointed widely-experienced healthcare executives Jean-Michel Cosséry and Rudy Mareel as Non-Executive Directors.
Each of Owen Hughes, Bob Ingram, Darragh Lyons, who will continue in his current role as Chief Financial Officer, Kieran McGowan and Donal O’Connor, will step down from the Malin board with immediate effect. Dr Adrian Howd will continue to serve as Malin’s Chief Executive Officer and as a member of the board of directors. Liam Daniel will continue to serve as Lead Independent Non-Executive Director.
Ian Curley has had a long career in business and was most recently the Chief Executive Officer of Ardagh Group S.A., which is listed on the NYSE. He previously served as Chief Financial Officer of Smurfit Kappa Group plc, a FTSE 100 company.
Dr. Jean-Michel Cosséry was Vice President, North American Oncology, at Eli Lilly and Company (NYSE listed) and someone with global leadership experience in healthcare. Rudy Mareel is currently CEO of Polyganics, a privately held medical technology company, and a seasoned executive with in-depth understanding of the global healthcare market.
Donal O’Connor, the outgoing chairman of Malin said: “as advised in my Chairman’s Letter dated 14 March 2018, the Board has been working to identify and appoint at least two new Non-Executive Directors before our 2018 AGM. Following a period of engagement with certain shareholders, five of the current directors are stepping down and, three new Non-Executive Directors are today being appointed to the Board. I wish Ian, Jean-Michel and Rudy every success in their new roles. Ian has the ideal skills and expertise to lead the board of Malin and to deliver on our high-quality portfolio of investments and I look forward to supporting him in a seamless transition to his new role.”
Ian Curley, incoming Chairman of Malin, commented: “I would like to thank Bob, Kieran, Owen, and Donal for their significant contributions and commitment to the Company. In particular, I would like to acknowledge Donal who has agreed to make himself available to me and the Board in this time of Board transition. I am delighted to take up this position as I believe Malin has a unique opportunity to create extensive shareholder value by applying our capital and expertise to our investee companies. I will be totally focused on translating this potential into value for our shareholders and on closing the gap between the intrinsic value of our assets and our share price. I and the Board look forward to working with the management team in the coming years to deliver on these goals.”
The Board will undertake an extensive review of the Company’s portfolio and development strategy with a view to updating shareholders at its upcoming AGM in September, followed by a fuller presentation of the Company’s outlook and vision at a Capital Markets Day in Q4 2018, details of which will be announced in due course.
For more information : http://www.malinplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
